Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

Early recognition and a multidisciplinary approach are crucial for effectively managing complex autoimmune conditions like SLE with CAPS and AHA.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

Both skin products were equally effective in improving facial discoloration and skin quality.

Oral cyclosporine A and prednisolone effectively improved alopecia universalis without side effects.

Platelet-rich plasma therapy may rarely trigger herpes zoster ophthalmicus.

The study developed a method to detect minoxidil and its sulfate form, found that minoxidil sulfate is temperature-sensitive, and identified a way to potentially increase its stability for hair loss treatment.

Systemic corticosteroids can cause unusual skin issues in people with juvenile rheumatoid arthritis.

Hair regrowth was achieved using 5-Fluorouracil and Bleomycin for scalp atrophy caused by corticosteroids.

Glucocorticoid treatment in lupus can cause oral lesions, which need early diagnosis and comprehensive care.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Micelles can change cetirizine's ionization, affecting its effectiveness in treatments.

Intravenous cyclophosphamide effectively treated steroid-resistant lupus cystitis and peritonitis.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

Surgical excision is the best treatment for SCC.

Azathioprine effectively and safely treats alopecia areata.

Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.

High-dose UVA-1 therapy improves symptoms and skin condition in sclerosing skin disease.

The cosmetic product improved melasma and skin quality without causing irritation.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Fibromyalgia slightly more common in SLE patients but doesn't affect SLE activity assessments.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.